Serum Tumour Markers in Lung Cancer

References

• Azzopardi JG. Oat cell carcinoma of the bronchus. J Path Bact 1959; 78: 513–9
   PubMedGoogle Scholar
• Watson W L, Berg JW. Oat cell lung cancer. Cancer 1962; 15: 759–68
   PubMedGoogle Scholar
• Gold P, Freedman SO. Demonstration of tumor specific antigens in humane colonic carcinomata by immunologic tolerance and absorption techniques. J Exp Med 1965; 121: 439–62
   PubMed Web of Science ®Google Scholar
• Stevens D P, Mackay IR. Increased carcinoembryonic antigen in heavy cigarette smokers. Lancet 1973; 2: 1238–9
   PubMed Web of Science ®Google Scholar
• Bates S E, Longo DL. Use of serum tumor markers in cancer diagnosis and management. Sem Oncol 1987; 14: 102–38
   PubMed Web of Science ®Google Scholar
• Concannon J P, Dalbow M H, Hodgson SE, et al. Prognostic value of preoperative carcinoembryonic antigen levels in patients with bronchogenic carcinoma. Cancer 1978; 42: 1477–83
   PubMedGoogle Scholar
• Vincent R G, Chu T M, Lane WW. The value of carcinoembryonic antigen in patients with carcinoma of the lung. Cancer 1979; 44: 685–91
   PubMed Web of Science ®Google Scholar
• Goslin R H, Skarin A T, Zamchech N. Carcinoembryonic antigen. A useful monitor of small cell lung cancer. JAMA 1981; 246: 2173–6
   PubMed Web of Science ®Google Scholar
• Lokich JJ. Plasma CEA levels in small cell lung cancer. Correlation with stage, distribution of metastases, and survival. Cancer 1982; 50: 2154–6
   PubMed Web of Science ®Google Scholar
• Waalkes T P, Abelof M D, Woo KB, et al. Carcinoembryonic antigen for monitoring patients with small cell carcinoma of the lung during treatment. Cancer Res 1980; 40: 4420–7
   PubMed Web of Science ®Google Scholar
• Krischke W, Niederle N, Schii tte J, et al. Is there any clinical relevance of serial determination of serum carcinoembryonic antigen in small cell lung cancer patients?. Cancer 1988; 62: 1348–54
   PubMedGoogle Scholar
• Hansen M, Pedersen AG. Tumor Markers in patients with lung cancer. Chest 1986; 89: 219s–24s
   Web of Science ®Google Scholar
• Sappino A P, Ellison M L, Carter SC, et al. Correlation of 3 tumour markers (Calcitonin, CEA, and beta-hCG) with response to therapy and extend of disease in small cell lung cancer. Br J Cancer 1981; 44: 300
   Google Scholar
• Wallach S R, Royston I, Taetle R, et al. Plasma Calcitonin as a marker of disease activity in patients with small cell carcinoma of the lung. J Clin Endocrinol Metab 1981; 53: 602–6
   PubMedGoogle Scholar
• Hansen M, Hansen H H, Tryding N. Small cell carcinoma of the lung: Serum Calcitonin and serum histaminase (diamine oxidase) at basal levels and stimulated by pentagastrin. Acta Med Scand 1978; 204: 257–61
   PubMedGoogle Scholar
• Greco F A, Hainsworth J, Sismani A, . Hormone production and paraneoplastic syndromes. Small Cell Lung Cancer, FA Greco, RK Oldham, PA Biunn, et al. Grune & Stratton, Orlando, FL 1981; 177–223
   Google Scholar
• Hansen M, Hammer M, Hummer L. ACTH, ADH and calcitonin concentrations as markers of response and relapse in small cell carcinoma of the lung. Cancer 1980; 46: 2062–7
   PubMed Web of Science ®Google Scholar
• Hansen M. Clinical implications of ectopic hormone production in small cell carcinoma of the lung. Dan Med Bull 1981; 28: 221–36
   PubMedGoogle Scholar
• Biran H, Feld R, Sagman U, et al. Carcinoembryonic antigen, arginine vasopression, and calcitonin as markers of early small-cell lung cancer relapse. Tumor Biol 1989; 258–67
   PubMedGoogle Scholar
• Gewirtz G, Yalow RS. Ectopic ACTH production in carcinoma of the lung. J Clin Invest 1974; 53: 1022–32
   PubMed Web of Science ®Google Scholar
• Wolf sen AR, Odell WA. Pro ACTH: use for early detection of lung cancer. Am J Med 1979; 66: 765–72
   PubMedGoogle Scholar
• Hansen M, Hammer M, Hummer L. Diagnostic and theapeutic implications of ectopic hormone production in small cell carcinoma of the lung. Thorax 1980; 35: 101–6
   PubMed Web of Science ®Google Scholar
• North W G, Maurer L H, O'Donnell JF. The neurophysins and small cell lung cancer. Biology and Management of Lung Cancer, FA Greco. Martinus Nijhoff, Boston 1983; 143–169
   Google Scholar
• North W G, Ware J, Maurer LH, et al. Neurophysins as tumor markers for small cell carcinoma of the lung Cancer 1988; 62: 1343–7
   Google Scholar
• Sausville E A, Lebacq -Verheyden A M, Spindel ER, et al. Expression of the gastrin-releasing peptide gene in human small cell lung cancer. J Biol Chem 1986; 261: 2451–7
   PubMed Web of Science ®Google Scholar
• Sorensen G D, Bloom S R, Ghatei MA, et al. Bombesin production by human small cell carcinoma of the lung. Regul Pept 1982; 4: 59–66
   PubMedGoogle Scholar
• Bork E, Hansen M, Urdal P, et al. Early detection of response in small cell broncogenic carcinoma by changes in serum concentrations of creatine kinase, neuron specific enolase, calcitonin, ACTH, serotonin and gastrin releasing peptide. Eur J Cancer Clin Oncol 1988; 24: 1033–8
   PubMedGoogle Scholar
• Pert C B, Schumacher UK. Plasma Bombesin contrations in patients with extensive small cell carcinoma of the lung. Lancet 1982; 1: 509
   PubMed Web of Science ®Google Scholar
• Wood S M, Wood J R, Ghatei MA, et al. Js Bombesin a tumour marker for small cell carcinoma?. Lancet 1982; 1: 690–1
   PubMedGoogle Scholar
• Maruno K, Yamaguchi K, Abe K, et al. Immunoreactive gastrin-releasing peptide as a specific tumor marker in patients with small-cell lung carcinoma. Cancer Res 1989; 49: 629–32
   PubMed Web of Science ®Google Scholar
• Hoist J J, Hansen M, Bork E, et al. Elevated plasma concentrations of C- flanking gastrin-releasing peptide in small cell lung cancer. J Clin Oncol 1989; 7: 1831–8
   PubMedGoogle Scholar
• Pedersen A G, Becker K L, Bach F, et al. Cerebrospinal fluid, bomesin and calcitonin in patients with central nervous system metastases from small cell lung cancer. J Clin Oncol 1986; 4: 1620–7
   PubMed Web of Science ®Google Scholar
• Coolen RB, Progay DA, Nosenchuk JS, et al. Elevation of brain-type creatine kinase in serum from patients with carcinoma. Cancer 1979; 44: 1414–8
   PubMed Web of Science ®Google Scholar
• Rubery E D, Doran J F, Thompson PJ. Brain-type creatine kinase BB as a potential tumor marker-serum levels measured by radio-immunoassay in 1015 patients with histologically confirmed malignancies. Eur J Cancer Clin Oncol 1981; 18: 951–6
   Google Scholar
• Carney DN, Zweig MH, Bide DC, et al. Elevated serum creatine kinase BB levels in patients with small cell lung cancer. Cancer Res 1984; 44: 5399–403
   PubMed Web of Science ®Google Scholar
• Jacques G, Bepler G, Holle R, et al. Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatine kinase-BB levels in sera of patients with small-cell lung cancer. Cancer 1988; 62: 125–34
   PubMedGoogle Scholar
• Kato K, Ariyoshi Y, Nakajima T. Creatine kinase B subunit as a biomarker for small c arcinoma of the lung: Comparison with alfa-enolase. Jpn J Cancer Res 1985; 76: 1162–7
   PubMedGoogle Scholar
• Pedersen A G, Bach F W, Nissen N, et al. Creatine Kinase BB and beta-2- microglobulin as markers of CNS metastases in patients with small cell lung cancer. J Clin Oncol 1985; 3: 1364–75
   PubMed Web of Science ®Google Scholar
• Carney D N, Marangos P J, Bide DC, et al. Serum neuron-specific enolase: A marker for disease extent and response to therapy of small-cell lung cancer. Lancet 1982; 1: 583–5
   PubMed Web of Science ®Google Scholar
• Esscher T, Bergh J, Steinholz L, et al. Neuron-specific enolase in small cell carcinoma of the lung: The value of combined immoinocytochemistry and serum determination. Anti-cancer Research 1989; 9: 1717–20
   PubMedGoogle Scholar
• Paus E, Risberg T. Establishment and evaluation of a radioimmunoassay for neuron-specific enolase. Tumor Biol 1989; 10: 23–30
   PubMedGoogle Scholar
• Wielders J PM, Bartels C T, Bank C MC, et al. The diagnostic value of neuron- specific enolase and carcino-embryonic antigen analyses in patients with carcinoma of the lung. J Clin Chem Clin Biochem 1990; 4: 225–31
   Google Scholar
• Esscher T, Steinholtz L, Berg J, et al. Neurone specific enolase: A useful diagnostic serum marker for small cell carcinoma of the lung. Thorax 1985; 40: 85–90
   PubMed Web of Science ®Google Scholar
• Viallard J L, Cailland D, Kantelip B, et al. Enzymatic determatination of serum neuron-specific enolase/serum non neuronal enolase ratio. Chest 1988; 93: 1225–33
   PubMedGoogle Scholar
• Akoun G M, Scarha H M, Milleron BJ, et al. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer. Chest 1985; 87: 39–43
   PubMed Web of Science ®Google Scholar
• Cooper E H, Splinter T AW, Bronwn DA, et al. Evaluation of a radio- immunoassay for neuron specific enolase in small cell lung cancer. Br J Cancer 1985; 52: 333–8
   PubMed Web of Science ®Google Scholar
• Fischbach W, Schwarz-Wallrauch C, Jany B. Neuron-specific enolase and thymidine kinase as an aid to the diagnosis and treatment monitoring of small cell lung cancer. Cancer 1989; 63: 1143–9
   PubMed Web of Science ®Google Scholar
• Jorgensen L GM, Hansen H H, Cooper EH. Neuron-specific enolase, carcino- embryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer. Eur J Cancer Clin Oncol 1989; 25: 123–8
   PubMedGoogle Scholar
• Johnson D H, Marangos P J, Forbes JT. Potential utility of serum neuron- specific enolase levels in small cell carcinoma of the lung. Cancer Res 1984; 44: 5409–14
   PubMed Web of Science ®Google Scholar
• Batandier C, Brambilla E, Nagy-Mignotte H, et al. Clinical value of an amplified electrophoretic determination of anolase isoenzymes in small cell lung carcinoma patients. Scand J Clin Lab Invest 1989; 49: 33–42
   PubMed Web of Science ®Google Scholar
• Burghuber O C, Worofka B, Schernthaner G, et al. Serum neuron-specific enolase is a useful tumour marker for small cell lung cancer. Cancer 1990; 65: 1386–90
   PubMedGoogle Scholar
• Harding M, McAllister J, Hulks G, et al. Neurone specific enolase (NSE) in small cell lung cancer: A tumour marker of prognostic significance?. Br J Cancer 1990; 61: 605–7
   PubMedGoogle Scholar
• Splinter T AW, Carney D N, Teeling M, et al. Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practice. J Cancer Res Clin Oncol 1989; 115: 400–1
   PubMedGoogle Scholar
• Nou E, Steinholtz L, Bergh J, et al. Neuron-specific enolase as a follow-up marker in small cell bronchial carcinoma. Cancer 1990; 65: 1380–5
   PubMedGoogle Scholar
• Zandwijk N V, Jassem E, Bonfrer J MG, et al. Value of neuron specific enolase in early detection of relapse in small cell lung carcinoma. Eur J Cancer 1990; 26: 373–6
   PubMedGoogle Scholar
• Pedersen A GP, Marangos P, Becker KL, et al. Neuron specific enolase, bombesin and calcitonin in the CSF as markers of CNS metastaes from small cell carcinoma. Cancer Chemother Pharmacol. 1985; 14: 28, Suppl.
   Google Scholar
• Aroney R S, Dermody W C, Aldenderfer P, et al. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung. Cancer Treat Rep 1984; 68: 859–66
   PubMedGoogle Scholar
• Graziano S L, Mazid R, Newman N. the use of neuroendocrine immunperoxidase markers to predict chemotherapy response in patients with non- small cell lung Cancer. J Clin Oncol 1989; 7: 1398–1406
   PubMed Web of Science ®Google Scholar
• Berthiot G, Marechal F, Cattan A, et al. Serum levels of CH-50, CA 199. CA-125, neuron specific enolase and carcinoembryonic antigen in lung cancer and benign diseases of the lung. Biomed & Pharmacother 1989; 43: 613–20
   PubMedGoogle Scholar
• Diez M, Gerdan F J, Ortega MD, et al. Evaluation of serum CA 125 as a tumor marker in non-small cell lung cancer. Cancer 1991; 67: 150–4
   PubMedGoogle Scholar
• Kimura Y, Fujii T, Hamanoto K, et al. Serum CA-125 level is a good prognostic indicator in lung cancer. Br J Cancer 1990; 62: 676–8
   PubMed Web of Science ®Google Scholar
• Lombardi C, Tassi G F, Pizzocolo G, et al. Clinical significance of a multiple biomarker assay in patients with lung cancer. Chest 1990; 97: 639–44
   PubMed Web of Science ®Google Scholar
• Mizushima Y, Hirata H, Izumi S, et al. Clinical Significance of the number of positive tumor markers in assisting the diagnosis of lung cancer with multiple tumor marker assay. Oncology 1990; 47: 43–8
   PubMed Web of Science ®Google Scholar
• Mino N, Iio A, Hamarnoto K. Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs. Cancer 1988; 62: 730–4
   PubMed Web of Science ®Google Scholar
• Body J J, Soulier J P, Raymakers N, et al. Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer. Cancer 1990; 654: 1552–56
   Google Scholar